Q2 2018 Holdings
Filed 2018-08-14 | 44 holdings | $111.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $42.9M | 7,478,275 | 38.4% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $30.5M | 2,000,000 | 27.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $25.6M | 260,100 | 23.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $12.0M | 1,444,481 | 10.7% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $52.9K | 1,568,500 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $47.8K | 2,627,110 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $44.6K | 3,485,745 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $41.4K | 500,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $36.8K | 758,000 | 0.0% |
| Zafgen Inc | COM | 98885E103 | $35.8K | 3,500,000 | 0.0% |
| Global Blood Therapeutics Inc | COM | 37890U108 | $34.8K | 770,400 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $28.7K | 1,334,793 | 0.0% |
| Global Blood Therapeutics IncCall | COM | 37890U108 | $27.2K | 602,200 | 0.0% |
| Acceleron Pharma Inc(XLRN)Put | COM | 00434H108 | $26.8K | 552,300 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $24.0K | 4,781,708 | 0.0% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $22.3K | 713,998 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $19.9K | 1,260,000 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $19.2K | 169,639 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $14.3K | 730,010 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $13.7K | 110,506 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $13.3K | 1,174,541 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $13.2K | 302,000 | 0.0% |
| Corsicanto II Designated ACT | NOTE | 220485AB2 | $10.9K | 10,000,000 | 0.0% |
| Exelixis Inc(EXEL)Call | COM | 30161Q104 | $10.8K | 500,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $9.9K | 1,473,609 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $9.6K | 3,407,840 | 0.0% |
| Global Blood Therapeutics IncPut | COM | 37890U108 | $9.0K | 200,000 | 0.0% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $8.5K | 2,988,716 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM NEW | 12648L601 | $7.7K | 1,537,020 | 0.0% |
| Sierra Oncology Inc | COM | 82640U107 | $6.8K | 2,280,921 | 0.0% |
| Acceleron Pharma Inc(XLRN)Call | COM | 00434H108 | $5.2K | 107,900 | 0.0% |
| Amarin Corp PLCCall | SPONS ADR NEW | 023111206 | $4.9K | 1,596,200 | 0.0% |
| Acorda Therapeutics IncCall | COM | 00484M106 | $4.2K | 145,900 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $3.3K | 1,056,825 | 0.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $2.5K | 759,494 | 0.0% |
| Celldex Therapeutics Inc New | COM | 15117B103 | $405 | 804,483 | 0.0% |
| Streamline Health Solutions | COM | 86323X106 | $183 | 130,137 | 0.0% |
| Novelion Therapeutics Inc | COM NEW | 67001K202 | $9 | 2,500 | 0.0% |